Healthcare >> CEO Interviews >> February 26, 2013
Steven Quay, M.D., Ph.D., FCAP, is Chief Executive Officer and Chairman of the board for Atossa Genetics, Inc. Dr. Quay is a board-certified Anatomic Pathologist, with training at The Massachusetts General Hospital, Harvard Medical School and the chemistry department, Massachusetts Institute of Technology, and is a former faculty member of the department of pathology, Stanford University School of Medicine. Dr. Quay is a member of the American Society of Investigative Pathology, the Association of Molecular Pathology, the Society for Laboratory Automation and Screening, and the Association of Pathology Informatics. Profile
TWST: Let's start with a quick overview of Atossa Genetics and how you view the company at this point?
Dr. Quay: Atossa Genetics, the Breast Health Company, was founded in 2009. Our